Rebecca Adams Selected Research

Ichthyosis (Xeroderma)

11/2017

Autosomal recessive congenital ichthyosis: CERS3 mutations identified by a next generation sequencing panel targeting ichthyosis genes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rebecca Adams Research Topics

Disease

6	Neoplasms (Cancer) 03/2024 - 11/2021
5	Melanoma (Melanoma, Malignant) 03/2024 - 11/2021
1	Leukemia 10/2023
1	Eosinophilia 10/2023
1	Autoimmune Diseases (Autoimmune Disease) 01/2023
1	Venous Thromboembolism 01/2023
1	Disseminated Intravascular Coagulation 01/2023
1	Purpura Fulminans 01/2023
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Shock 01/2022
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2022
1	Neoplasm Metastasis (Metastasis) 11/2021
1	Empyema 06/2020
1	Delirium 06/2020
1	Seizures (Absence Seizure) 06/2020
1	Brain Diseases (Brain Disorder) 06/2020
1	Acute Kidney Injury (Acute Renal Failure) 06/2020
1	Hallucinations (Hallucination) 06/2020
1	Chronic Kidney Failure (Chronic Renal Failure) 06/2020
1	Paraproteinemias (Monoclonal Gammopathy) 01/2019
1	Ichthyosis (Xeroderma) 11/2017
1	Infections 11/2016
1	Hepatitis 11/2016
1	Personality Disorders (Personality Disorder) 12/2013
1	Schizophrenia (Dementia Praecox) 12/2013
1	Paranoid Personality Disorder 12/2013
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 03/2009

Drug/Important Bio-Agent (IBA)

3	AntibodiesIBA 01/2023 - 01/2022
2	Monoclonal AntibodiesIBA 01/2022 - 01/2022
1	AutoantigensIBA 01/2023
1	Dacarbazine (DIC)FDA LinkGeneric 01/2023
1	AntigensIBA 01/2023
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 01/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Immune Checkpoint ProteinsIBA 01/2022
1	PlasticsIBA 01/2022
1	ChemokinesIBA 11/2021
1	Biomarkers (Surrogate Marker)IBA 11/2021
1	Ertapenem (Invanz)FDA Link 06/2020
1	Carbapenems (Carbapenem Antibiotics)IBA 06/2020
1	ParaproteinsIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 11/2017
1	Interleukin-27 (Interleukin 27)IBA 11/2016
1	Antiviral Agents (Antivirals)IBA 11/2016
1	Tuberculin (PPD)IBA 12/2013
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 03/2009

Therapy/Procedure

5	Therapeutics 03/2024 - 11/2021
2	Immunotherapy 03/2024 - 11/2021
1	Drug Therapy (Chemotherapy) 10/2023
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2022
1	Secondary Prevention 01/2022